You can buy or sell Taro and other stocks, options, ETFs, and crypto commission-free!
Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Read More The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
Haifa Bay, Haifa
52 Week High
52 Week Low
Advertising and Marketing
Simply Wall StMar 12
Do You Like Taro Pharmaceutical Industries Ltd. (NYSE:TARO) At This P/E Ratio?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We’ll show how you can use Taro Pharmaceutical Industries Ltd.’s (NYSE:TARO) P/E ratio to inform your assessment of the investment opportunity. Based on the last twelve months, Taro Pharmaceutical Industries’s P/E ratio is 13.32. That means that at current prices, buyers pay $13.32 for every $1 in trailing yearly profits. See our latest analysis for Taro Pharmaceutical Industries How Do I Calculate A P...
Yahoo FinanceMar 8
Moving Average Crossover Alert: Taro Pharmaceutical
Taro Pharmaceutical Industries Ltd. TARO is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for TARO broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend. This has already started to take place, as the stock has moved higher by 11.9% in the past four weeks. Plus, the company currently has a Zacks Rank #1 (Strong Buy) suggesting that now coul...
Yahoo FinanceMar 4
Top Ranked Momentum Stocks to Buy for March 4th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th: America's Car-Mart, Inc. (CRMT): This automotive retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.1% over the last 60 days. America's Car-Mart, Inc. Price and Consensus America's Car-Mart, Inc. Price and Consensus More America's Car-Mart, Inc. price-consensus-chart | America's Car-Mart, Inc. Quote America's Car-...
Expected May 16, After Hours